onic obstructive pulmonary disease with poor reversibility：a systematic review of randomised controlled trials[J].BMC Pulm Med，2004，4:717.
[6] Barnes NC，Qiu YS，Pavord ID，et al. Antiinflammatory effects of salmeterol/fluticasone Propionate in chronic obstructive lung disease[J]. Am J Respir Crit Care Med，2006，173(7):736743.
[7] Calverley PM，Boonsawat W，Cseke Z，et al. Maintenance therapy with budesonide and formoterol in chronic obstructive pulmonary disease[J]. Eur Respir J，2003，22 (6):912919.
[8] Calverley PM，Pauwels R，Vestbo J，et al. Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease：a randomised controlled trial[J]. Lancet，2003，361(9356):449456.
[9]Szafranski W，Cukier A，Ramirez A，et al. Efficacy and safety of budesonide/formoterol in the management of chronic obstructive pulmonary disease[J]. Eur Respir J，2003，21(1):7481.
[10]Calverley PM，Anderson JA，Celli B，et al. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease[J]. N Engl J Med，2007，356(8)：775789.
[11]Calverley PM， Rennard S. What have we learned from large drug treatment trials in COPD? [J]. Lancet，2007，370(9589):774785.
仁和医学论文网专业提供代写代发医学论文服务，并提供大量论文资料，如有业务需求请咨询网站客服人员!
上一页 [1] [2] [3]
您现在的位置： 绿色健康网 >> 医学论文 >> 内科论文 >> 正文